Cushman & Wakefield's specialized Life Sciences Group is a global team of professionals whose focus is advising clients in the life sciences industries which includes biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, nutraceuticals, environmental and biomedical devices. Making the correct real estate decisions means being in the right location, at the right cost and at the right time for your staff, your clients and your business.
Our real estate knowledge can help you improve:
- flexibility in up-scaling and down-scaling commercial operations
- attracting and retaining top scientific talent
- adapting real estate needs to meet emerging therapeutic fields
- migrating to lower cost environments
- shedding -surplus liabilities
- monetising underutilised assets
Drawing from a broad experience, our team of consultants and transaction specialists add unique value by helping align real estate portfolios with company business goals with the services such as Business Consulting, Occupier Strategy, Lease administration, Transaction Management, Location Studies, Project Management & Consultancy, Valuation & Advisory, specialized Research & Insight and maket analytics.
Click here to visit our Research & Insight section to read our latest reports on Life Science.
Cushman & Wakefield's corporate clients include companies such as Pfizer, Humana, Icon, Novartis, Merck Services, Bayer, Gsk, Abbott, Humana, Abraxis, Genzyme, Coram, AbbviePRA and Micron.